Sign In
Buy TMCI
$2.89
-0.140 (-4.62%)
At Close: Nov 17, 2025
Treace Medical Concepts, Inc. (TMCI) Q3 2025 Earnings Call Transcript
11:36am, Friday, 07'th Nov 2025
Treace Medical Concepts, Inc. ( TMCI ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Trip Taylor John Treace - Founder, Chairman & CEO Mark Hair - Chief Financial Officer Con
Treace Announces Participation in Two Upcoming Investor Conferences
08:05am, Friday, 07'th Nov 2025
PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates
06:41pm, Thursday, 06'th Nov 2025
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.25 per share a year ago.
Y Intercept Hong Kong Ltd Raises Stake in Treace Medical Concepts, Inc. $TMCI
03:41am, Monday, 03'rd Nov 2025
Y Intercept Hong Kong Ltd lifted its stake in shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) by 645.8% in the undefined quarter, according to its most recent 13F filing with the Securities and
Treace Medical Concepts (TMCI) Projected to Post Quarterly Earnings on Thursday
02:42am, Thursday, 30'th Oct 2025
Treace Medical Concepts (NASDAQ: TMCI - Get Free Report) is projected to issue its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings o
Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
04:05pm, Thursday, 23'rd Oct 2025
PONTE VEDRA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
PONTE VERDE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
Treace Medical Concepts, Inc. (TMCI) Investor Day 2025 Call Transcript
08:13pm, Wednesday, 03'rd Sep 2025
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Investor Day Call September 3, 2025 9:00 AM EDT Company Participants John Treace - Founder, Chairman & CEO Sean Scanlan - Chief Innovation Officer Conferen
Treace Medical Concepts, Inc. (TMCI) Q2 2025 Earnings Call Transcript
06:09am, Friday, 08'th Aug 2025
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants John T. Treace - Founder, Chairman & CEO Mark L.
Treace Medical (TMCI) Q2 Revenue Up 7%
10:20pm, Thursday, 07'th Aug 2025
Treace Medical (TMCI) Q2 Revenue Up 7%
Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates
07:06pm, Thursday, 07'th Aug 2025
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.34 per share a year ago.
Treace Medical Concepts Reports Second Quarter 2025 Financial Results
04:05pm, Thursday, 07'th Aug 2025
PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025
04:01pm, Thursday, 07'th Aug 2025
PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
PHILADELPHIA, July 01, 2025 (GLOBE NEWSWIRE) -- Maison Solutions Inc. (NASDAQ: MSS) Class Action Survives Motion to Dismiss:
Kuehn Law Encourages Investors of Treace Medical Concepts, Inc. to Contact Law Firm
10:08am, Wednesday, 11'th Jun 2025
NEW YORK , June 11, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Treace Medical Concepts, Inc. (NASDAQ: TMCI) b
